6SJA Stock Chart & Stats
€0.72
-€0.03(-4.13%)
At close: 4:00 PM EDT
€0.72
-€0.03(-4.13%)
Day’s Range― - ―
52-Week Range€0.32 - €1.82
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€57.22M
Enterprise Value€835.20M
Total Cash (Recent Filing)€20.72M
Total Debt (Recent Filing)€398.02M
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Oct 29, 2026EPS Estimate
-0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding179,261,800
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.24
Price to Sales (P/S)0.10
P/FCF Ratio5.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€1.93Price Target Upside167.75% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.11
Revenue Forecast (FY)€1.49B
Bulls Say, Bears Say
Bulls Say
Debt ReductionThe sharp reduction in debt materially lowers financial risk and improves SelectQuote’s flexibility to fund operations, invest in technology, and withstand industry volatility. A stronger balance sheet can also reduce refinancing dependence and allow more operating cash flow to support strategic priorities.
Healthcare Services ProfitabilityHealthcare Services is developing into a meaningful earnings contributor, combining stabilized membership with improving profitability. The segment’s margin trajectory and long-term low-double-digit target could diversify earnings, strengthen consolidated margins, and make the business less dependent on enrollment volume alone.
Recurring High-Margin DistributionSustained mid-20% Senior margins across four years demonstrate resilience in SelectQuote’s agent-led distribution model. Life Insurance growth and cash-efficient earnings add another durable contributor, supporting business quality through recurring commissions, carrier breadth, and disciplined customer acquisition.
Bears Say
FY2027 Revenue ContractionThe projected top-line decline indicates that improved profitability will initially rely on cost actions and mix rather than expanding demand. Lower revenue can reduce operating leverage, constrain future investment, and make earnings more sensitive to policy volumes, carrier decisions, and industry conditions.
High Funding CostsA costly capital structure absorbs substantial cash that could otherwise fund growth, technology, or debt reduction. The interest burden also leaves less protection if operating performance weakens, while refinancing or repricing would remain important to improving long-term earnings conversion.
Uneven Cash ConversionRecent cash improvement is encouraging, but the multi-year pattern remains volatile and makes earnings quality less predictable. Inconsistent operating and free cash flow can limit internally funded investment, complicate deleveraging, and increase dependence on sustained execution to prove profitability is durable.
SelectQuote News
6SJA FAQ
What was SelectQuote’s price range in the past 12 months?
SelectQuote lowest stock price was €0.32 and its highest was €1.82 in the past 12 months.
What is SelectQuote’s market cap?
SelectQuote’s market cap is €57.22M.
When is SelectQuote’s upcoming earnings report date?
SelectQuote’s upcoming earnings report date is Oct 29, 2026 which is in 17 days.
How were SelectQuote’s earnings last quarter?
SelectQuote released its earnings results on Aug 25, 2026. The company reported -€0.169 earnings per share for the quarter, missing the consensus estimate of -€0.147 by -€0.022.
Is SelectQuote overvalued?
According to Wall Street analysts SelectQuote’s price is currently Undervalued.
Does SelectQuote pay dividends?
SelectQuote does not currently pay dividends.
What is SelectQuote’s EPS estimate?
SelectQuote’s EPS estimate is -0.29.
How many shares outstanding does SelectQuote have?
SelectQuote has 179,261,800 shares outstanding.
What happened to SelectQuote’s price movement after its last earnings report?
SelectQuote reported an EPS of -€0.169 in its last earnings report, missing expectations of -€0.147. Following the earnings report the stock price went down -2.797%.
Which hedge fund is a major shareholder of SelectQuote?
Currently, no hedge funds are holding shares in DE:6SJA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SelectQuote Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-81.50%
12-Months-Change
Fundamentals
Return on Equity
10.03%
Trailing 12-Months
Asset Growth
2.40%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
SelectQuote
SelectQuote, Inc. operates as a tech-driven, direct-to-consumer marketplace, offering a wide spectrum of insurance products to individuals throughout the United States. These policies are underwritten by a variety of insurance carriers. The company structures its operations across three core divisions: Senior, Life, and Auto & Home. Within its Senior segment, SelectQuote provides access to a comprehensive suite of health policies, including Medicare Advantage, Medicare Supplement, and Medicare Part D plans. This segment also features ancillary coverages such as prescription drug plans, dental, vision, and hearing benefits. The Life division concentrates on term life insurance offerings, while the Auto & Home segment delivers personal automobile, homeowners', and general casualty insurance solutions. Established in 1999, SelectQuote, Inc. is headquartered in Overland Park, Kansas.
6SJA Company Deck
6SJA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a balanced picture: strong execution on profitability and cash flow (notably a $44M year-over-year operating cash flow improvement, Healthcare Services inflection to a near $50M annual EBITDA run rate, and >$30M of identified cost savings) contrasted with meaningful top-line headwinds (guidance implying ~14% revenue decline in 2027), ongoing Medicare Advantage market volatility, IRA-related revenue pressure, and a relatively high-cost capital structure (~$800M at ~12%). Management is prioritizing cash generation and deleveraging over growth in fiscal 2027, which supports a constructive longer-term view but leaves notable near-term revenue and capital risks.View all DE:6SJA earnings summaries6SJA Stock 12 Month Forecast
Average Price Target
€1.93
▲(167.75% Upside)